Swedish Orphan Biovitrum

Shanghai, Fudan

OncologyFiled/ApprovedListed · SOBI.ST

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Study registered, no phase assigned: Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

1w agoTrial registeredJul 8, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
I01 · non-dilutive
Jun 1, 2026
VA EASTERN COLORADO HEALTH CARE SYSTEM · PI SIMONETTI, JOSEPH A · VA · award ends May 31, 2030 · Identifying and Characterizing Firearm Storage Practices; Causal Links to Veteran Suicide
NIH RePORTER · NIH RePORTER 11337895 (opens the source filing in a new tab)
Grant
P30 · $293k · non-dilutive
Jun 15, 2025
UT SOUTHWESTERN MEDICAL CENTER · PI ZHANG, RONG · NIA · award ends Mar 31, 2030 · North Texas ADRC - Research Education Component
NIH RePORTER · NIH RePORTER 11117641 (opens the source filing in a new tab)
Grant
F30 · $35k · non-dilutive
May 1, 2025
VANDERBILT UNIVERSITY · PI ZHANG, RAYMOND J · NCI · award ends Apr 30, 2028 · VISTA-Mediated Immune Evasion in High-Risk Myelodysplastic Syndrome
NIH RePORTER · NIH RePORTER 11069224 (opens the source filing in a new tab)
Trial
NA registered
Mar 3, 2025
Tobacco Use Cessation, Addiction · ENROLLING_BY_INVITATION · sponsor: Stanford University · An Evaluation of the Tobacco Prevention Toolkit Healthy Futures: Alternative-to-Suspension Vaping Intervention
ClinicalTrials.gov · NCT06483412 (opens the source filing in a new tab)
Trial
Study registered
Mar 1, 2025
Chronic Kidney Disease(CKD), Type 1 Diabetes (T1D) · RECRUITING · sponsor: The Cleveland Clinic · Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
ClinicalTrials.gov · NCT06694558 (opens the source filing in a new tab)
Trial
Study registered
Dec 1, 2024
Acute Respiratory Failure, Ventilator Weaning Assessment · COMPLETED · sponsor: Ruijin Hospital · Electrical Impedance Tomography-derived Flow Index During Spontaneous Breathing Trial Stratifies the Risk of Reintubation Within 48 h After Extubation
ClinicalTrials.gov · NCT06876792 (opens the source filing in a new tab)
Grant
R01 · $673k · non-dilutive
Aug 1, 2024
STANFORD UNIVERSITY · PI BARNA, MARIA · NIDDK · award ends May 31, 2029 · Investigating and targeting the translational landscape of DBA
NIH RePORTER · NIH RePORTER 11136935 (opens the source filing in a new tab)
Grant
R01 · $1.2M · non-dilutive
Sep 1, 2023
UT SOUTHWESTERN MEDICAL CENTER · PI DING, KAN · NINDS · award ends May 31, 2028 · Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury (CAPCOG-TBI)
NIH RePORTER · NIH RePORTER 11099994 (opens the source filing in a new tab)
Grant
U2C · $833k · non-dilutive
Sep 1, 2023
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KU, ELAINE · NIDDK · award ends Jun 30, 2028 · Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
NIH RePORTER · NIH RePORTER 11132621 (opens the source filing in a new tab)
Grant
U2C · $833k · non-dilutive
Sep 1, 2023
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KU, ELAINE · NIDDK · award ends Jun 30, 2028 · Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
NIH RePORTER · NIH RePORTER 11361154 (opens the source filing in a new tab)
Trial
PHASE4 registered
Feb 3, 2023
Primary Hemophagocytic Lymphohistiocytosis · COMPLETED · sponsor: Swedish Orphan Biovitrum · A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients
ClinicalTrials.gov · NCT05744063 (opens the source filing in a new tab)
Grant
R25 · $105k · non-dilutive
Sep 23, 2022
STANFORD UNIVERSITY · PI SAKAMOTO, KATHLEEN M · NIDDK · award ends Jun 30, 2027 · Increasing Interest in Hematology Research: Training for Promising Students
NIH RePORTER · NIH RePORTER 11393660 (opens the source filing in a new tab)
Grant
R01 · $763k · non-dilutive
Sep 1, 2022
UNIVERSITY OF MINNESOTA · PI ZHANG, RUI · NIA · award ends May 31, 2027 · Detecting synergistic effects of pharmacological and non-pharmacological interventions for AD/ADRD
NIH RePORTER · NIH RePORTER 11332277 (opens the source filing in a new tab)
Trial
PHASE2 registered
Apr 15, 2022
Hypertension · TERMINATED · sponsor: University of California, San Francisco · Hypertension in Young Adults Trial
ClinicalTrials.gov · NCT05370599 (opens the source filing in a new tab)
Trial
PHASE2 registered
Apr 10, 2018
Hypertension · COMPLETED · sponsor: University of Texas Southwestern Medical Center · Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)
ClinicalTrials.gov · NCT03354143 (opens the source filing in a new tab)
Grant
R01 · $671k · non-dilutive
Dec 6, 2017
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KU, ELAINE · NIDDK · award ends Mar 31, 2029 · Racial disparities in access to kidney transplantation
NIH RePORTER · NIH RePORTER 11043450 (opens the source filing in a new tab)
Grant
R01 · $669k · non-dilutive
Dec 6, 2017
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KU, ELAINE · NIDDK · award ends Mar 31, 2029 · Racial disparities in access to kidney transplantation
NIH RePORTER · NIH RePORTER 11362000 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
Shared principal investigator or founder links the trial record at 0.75grant to an academic institution linked by a shared principal investigator
new_entity links the trial record at 0.50name similarity 100%

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Investigators

The principal investigators named on the grants below. Each links to their federal grant record and every other company traced to their work.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
1w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
1w agoTrial recruitingSource (opens the source filing in a new tab)
NIH U2C · $0.8M · Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
5w agoGrant renewalSource (opens the source filing in a new tab)
NIH R25 · $0.1M · Increasing Interest in Hematology Research: Training for Promising Students
5w agoGrant renewalSource (opens the source filing in a new tab)
NIH I01 · Identifying and Characterizing Firearm Storage Practices; Causal Links to Veteran Suicide
6w agoNew grantSource (opens the source filing in a new tab)
NIH R01 · $0.8M · Detecting synergistic effects of pharmacological and non-pharmacological interventions for AD/ADRD
6w agoGrant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Racial disparities in access to kidney transplantation
2mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Electrical Impedance Tomography-derived Flow Index During Spontaneous Breathing Trial Stratifies the Risk of Reintubation Within 48 h After Extubation
2mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: Electrical Impedance Tomography-derived Flow Index During Spontaneous Breathing Trial Stratifies the Risk of Reintubation Within 48 h After Extubation
2mo agoTrial completedSource (opens the source filing in a new tab)
Filed/Approved trial registered: A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients
4mo agoTrial registeredSource (opens the source filing in a new tab)
Trial completed: A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients
4mo agoTrial completedSource (opens the source filing in a new tab)
Phase II trial registered: Hypertension in Young Adults Trial
6mo agoTrial registeredSource (opens the source filing in a new tab)
Study registered, no phase assigned: An Evaluation of the Tobacco Prevention Toolkit Healthy Futures: Alternative-to-Suspension Vaping Intervention
7mo agoTrial registeredSource (opens the source filing in a new tab)
Phase II trial registered: Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)
Jul 2025Trial registeredSource (opens the source filing in a new tab)
Trial completed: Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)
Jul 2025Trial completedSource (opens the source filing in a new tab)
NIH U2C · $0.8M · Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Racial disparities in access to kidney transplantation
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Investigating and targeting the translational landscape of DBA
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $1.2M · Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury (CAPCOG-TBI)
Jun 2025Grant renewalSource (opens the source filing in a new tab)
NIH P30 · $0.3M · North Texas ADRC - Research Education Component
Jun 2025New grantSource (opens the source filing in a new tab)
NIH F30 · $0.0M · VISTA-Mediated Immune Evasion in High-Risk Myelodysplastic Syndrome
Apr 2025New grantSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

I01 · non-dilutive

P30 · $293k · non-dilutive

F30 · $35k · non-dilutive

NA registered

Study registered

Study registered

R01 · $673k · non-dilutive

R01 · $1.2M · non-dilutive

U2C · $833k · non-dilutive

U2C · $833k · non-dilutive

PHASE4 registered

R25 · $105k · non-dilutive

R01 · $763k · non-dilutive

PHASE2 registered

PHASE2 registered

R01 · $671k · non-dilutive

R01 · $669k · non-dilutive